Showing results (71-80 of 300) with videos related to
Sort By:
Pageof 30
Leukemia|March 20, 2009
The complete evaluation of erythrocytosis: congenital and acquiredM M Patnaik, A TefferiBone Marrow Transplantation|November 2, 2004
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rateM A Gertz, M Q Lacy, A Dispenzieri, et al.Cytotherapy|June 24, 2006
Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CMLM R Litzow, A B Dietz, P A Bulur, et al.Journal of Hematotherapy & Stem Cell Research|November 25, 2000
Fatal pulmonary toxicity related to the administration of granulocyte colony-stimulating factor in amyloidosis: a report and review of growth factor-induced pulmonary toxicityM A Gertz, M Q Lacy, J Bjornsson, et al.Leukemia & Lymphoma|August 1, 1994
The 5q- syndrome: a scientific and clinical updateA Tefferi, P Mathew, P NoëlBone Marrow Transplantation|April 25, 2006
Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphomaF K Buadi, I N Micallef, S M Ansell, et al.Blood Cancer Journal|January 18, 2022
European LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall responseK H Begna, J Kittur, N Gangat, et al.Blood|July 27, 2001
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphomaL F Porrata, M A Gertz, D J Inwards, et al.Bone Marrow Transplantation|March 20, 1999
Early harvest and late transplantation as an effective therapeutic strategy in multiple myelomaM A Gertz, M Q Lacy, D J Inwards, et al.Croatian Medical Journal|July 27, 2001
Engineering dendritic cell grafts for clinical trials in cellular immunotherapy of cancer: example of chronic myelogenous leukemiaA B Dietz, M R Litzow, D A Gastineau, et al.Pageof 30